ESTHER MARTINBOROUGH (RIGHT) AND A COLLEAGUE AT CELGENE DISCUSS THE CHEMICAL STRUCTURE OF THE COMPANY’S S1P MODULATOR THAT IS CURRENTLY IN CLINICAL DEVELOPMENT FOR MS.

Esther Martinborough and colleague

ESTHER MARTINBOROUGH (RIGHT) AND A COLLEAGUE AT CELGENE DISCUSS THE CHEMICAL STRUCTURE OF THE COMPANY’S S1P MODULATOR THAT IS CURRENTLY IN CLINICAL DEVELOPMENT FOR MS.